What is TMDX's current stock price?

As of now, TMDX is trading at $125.03, with a daily change of +0.46%.

What are the risks associated with TMDX stock?

TMDX Key risk is its Moderate, .

What is TMDX next earnings date?

TMDX next earnings report is yet to be scheduled.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Earnings Calendar Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

TMDX Stock Analysis & IQ Rating | TransMedics Group In

TMDX

TransMedics Group In

$125.03

+$0.57 | +0.46%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Headlines

52W High

$ 145.5

MKT CAP

$ 4.25B

52W Low

$ 55

VOL

$ 396.60K

P/E Ratio

51.83

AVG VOL

$ 990.66K

RSI

52.59

TREND

Uptrend

TMDX Stock IQ

Login to see TransMedics Group In (TMDX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

TMDX Target Price

Login to display

Strengths

TMDX Rewards

Earnings are forecast to grow

TMDX Rewards

Upgraded on attractively valued

Chart

$112.98 (+10.67%)

$132.04 (-5.31%)

$141.96 (-11.93%)

$82.92 (+50.78%)

1year

6month

3month

1month

TMDX Risk Level

TMDX has Moderate risk level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Moderate

LOW

HIGH

TMDX Analysts Opinion

TMDX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

TMDX Analysts Opinion

TMDX Analysts opinion is positive and it remained unchanged from the past 3 months

TMDX Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

74%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

33%

80%

TMDX Street Opinion

TMDX Street view is bullish and have positive views on the near-term outlook

TMDX Performance Sentiment

Sentiments overview associated with TMDX events and the stock performance.

74%

21%

Positive

Negative

14 out of 19
events present

4 out of 19
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$131.54

Resistance
Price

$107.29

Current Price Range

$135.79

Show methods +

TMDX Earnings

The TTM reflects 12-month period, providing review of TMDX financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

531

442

242

+48.13%

Cost of Revenue

214

179

88

+55.94%

Gross Profit

318

262

154

+43.70%

Operating Exp

241

225

183

+14.76%

Operating Inc

77

37

-29

-

Net Interest Inc

-17

-14

-11

-

Interest Exp

14

11

+12.82%

Interest Inc

-

13

-

Other Inc Exp

13

-

EPS Growth

2.12

1.07

-0.77

-

TMDX Financial Health

The company financial health has moderately improved over the past year

Financial Score

3.7

TMDX Latest Analysis +

A Closer Look at TransMedics Groups Options Market Dynamics. High-rolling investors have positioned themselves ish on TransMedics Group (NASDAQ:) and it'.s important for retail traders to take note.\This activity came to our attention today through Benzinga'.s tracking of publicly available options data. The identities of these investors are uncertain but such a significant move in TMDX often signals that someone has privileged information.Today Benzinga'.s options scanner spotted 9

Mon Nov 3, 2025

$124.72 | -5.18%

Momentum

Potential

Heres Why TransMedics (TMDX) is a Strong Growth Stock. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.

Fri Oct 31, 2025

$131.54 | -3.13%

Potential

Canaccord Genuity Maintains TransMedics Group (TMDX) Buy Recommendation. Fintel reports that on October 30 2025 Canaccord Genuity maintained coverage of TransMedics Group (NasdaqGM:TMDX) with a Buy recommendation. Analyst Price Forecast Suggests 11.17% Upside

Thu Oct 30, 2025

$135.79 | +1.09%

Rating

Piper Sandler Maintains TransMedics Group (TMDX) Overweight Recommendation. Fintel reports that on October 30 2025 Piper Sandler maintained coverage of TransMedics Group (NasdaqGM:TMDX) with a Overweight recommendation. Analyst Price Forecast Suggests 11.17% Upside

Thu Oct 30, 2025

$135.79 | +1.09%

Rating

TMDX Stock Falls Despite Q3 Earnings Beat Estimates Revenues Up Y/Y. TransMedics posts surging profit and higher revenues on strong OCS and logistics growth yet its shares slide despite upbeat Q3 results.

Thu Oct 30, 2025

$135.79 | +1.09%

Earnings

Momentum

TransMedics: Q3 Results Disappointed As Expected (Rating Upgrade).

Thu Oct 30, 2025

$135.79 | +1.09%

Activity

Needham Upgrades TransMedics Group (TMDX). Fintel reports that on October 23 2025 Needham upgraded their outlook for TransMedics Group (NasdaqGM:TMDX) from Hold to Buy. Analyst Price Forecast Suggests 25.00% Upside

Thu Oct 23, 2025

$128.91 | +7.84%

Potential

Rating

TransMedics upgraded at Needham on strong US sales.

Thu Oct 23, 2025

$128.91 | +7.84%

Activity

Rating

FAQ About TMDX Stock Insights

What is TMDX current stock price?

What are TMDX stock strengths?

What risks are associated with TMDX stock?

When is TMDX next earnings report?

What is TMDX market cap and volume?

What is TMDX's current Stock IQ?

Should I buy TMDX stock right now?

Is TMDX a Strong Buy right now?

What does a 'Strong Buy' rating mean for TMDX?

What does a 'Strong Sell' rating mean for TMDX?

What factors influence TMDX's Stock IQ?

Explore our TMDX Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored TMDX Stock Strategies
Effective Risk Management

FIND US ON

Receive our TMDX Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

TMDX

TransMedics Group In

Current Price

$125.03

+$0.57 | +0.46%

52W High

$ 145.5

MKT CAP

$ 4.25B

52W Low

$ 55

VOL

$ 396.60K

P/E Ratio

51.83

AVG VOL

$ 990.66K

RSI

52.59

TREND

Uptrend

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

TMDX Rewards

Earnings are forecast to grow

TMDX Rewards

Upgraded on attractively valued

TMDX Stock IQ

Login to unlock TransMedics Group In (TMDX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$112.98 (+10.67%)

$132.04 (-5.31%)

$141.96 (-11.93%)

$82.92 (+50.78%)

1year

6month

3month

1month

TMDX Analysts Opinion

TMDX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

TMDX Analysts Opinion

TMDX Analysts opinion is positive and it remained unchanged from the past 3 months

TMDX Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

74%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

33%

80%

TMDX Street Opinion

TMDX Street view is bullish and have positive views on the near-term outlook

TMDX Risk Level

TMDX has Moderate risk level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Moderate

LOW

HIGH

TMDX Performance Sentiment

Sentiments overview associated with TMDX events and the stock performance.

74%

21%

Positive

Negative

14 out of 19
events present

4 out of 19
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$131.54

Resistance
Price

$107.29

Current Price Range

$135.79

Show methods +

TMDX Earnings

The TTM data reflects the most recent 12-month period, providing overview of TMDX financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

531

442

242

+48.13%

Cost of Revenue

214

179

88

+55.94%

Gross Profit

318

262

154

+43.70%

Operating Exp

241

225

183

+14.76%

Operating Inc

77

37

-29

-

Net Interest Inc

-17

-14

-11

-

Interest Exp

14

11

+12.82%

Interest Inc

-

13

-

Other Inc Exp

13

-

EPS Growth

2.12

1.07

-0.77

-

TMDX Financial Health

The company financial health has moderately improved over the past year

Financial Score

3.7

TMDX Latest Analysis

A Closer Look at TransMedics Groups Options Market Dynamics. High-rolling investors have positioned themselves ish on TransMedics Group (NASDAQ:) and it'.s important for retail traders to take note.\This activity came to our attention today through Benzinga'.s tracking of publicly available options data. The identities of these investors are uncertain but such a significant move in TMDX often signals that someone has privileged information.Today Benzinga'.s options scanner spotted 9

Mon Nov 3, 2025

$124.72 | -5.18%

Momentum

Potential

Heres Why TransMedics (TMDX) is a Strong Growth Stock. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.

Fri Oct 31, 2025

$131.54 | -3.13%

Potential

Canaccord Genuity Maintains TransMedics Group (TMDX) Buy Recommendation. Fintel reports that on October 30 2025 Canaccord Genuity maintained coverage of TransMedics Group (NasdaqGM:TMDX) with a Buy recommendation. Analyst Price Forecast Suggests 11.17% Upside

Thu Oct 30, 2025

$135.79 | +1.09%

Rating

Piper Sandler Maintains TransMedics Group (TMDX) Overweight Recommendation. Fintel reports that on October 30 2025 Piper Sandler maintained coverage of TransMedics Group (NasdaqGM:TMDX) with a Overweight recommendation. Analyst Price Forecast Suggests 11.17% Upside

Thu Oct 30, 2025

$135.79 | +1.09%

Rating

TMDX Stock Falls Despite Q3 Earnings Beat Estimates Revenues Up Y/Y. TransMedics posts surging profit and higher revenues on strong OCS and logistics growth yet its shares slide despite upbeat Q3 results.

Thu Oct 30, 2025

$135.79 | +1.09%

Earnings

Momentum

TransMedics: Q3 Results Disappointed As Expected (Rating Upgrade).

Thu Oct 30, 2025

$135.79 | +1.09%

Activity

Needham Upgrades TransMedics Group (TMDX). Fintel reports that on October 23 2025 Needham upgraded their outlook for TransMedics Group (NasdaqGM:TMDX) from Hold to Buy. Analyst Price Forecast Suggests 25.00% Upside

Thu Oct 23, 2025

$128.91 | +7.84%

Potential

Rating

TransMedics upgraded at Needham on strong US sales.

Thu Oct 23, 2025

$128.91 | +7.84%

Activity

Rating

Discover TMDX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of TMDX. We're here to help you make informed investment decisions today.

FIND US ON

Receive our TMDX Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

TMDX Stock trends

TMDX Stock performance

TMDX Stock analysis

TMDX investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing TMDX

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing TMDX

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

TMDX Stock Analysis & IQ Rating | TransMedics Group In

TMDX Stock IQ

TMDX Target Price

TMDX Risk Level

TMDX Analysts Opinion

TMDX Street Consensus

TMDX Performance Sentiment

Technical Price Levels

TMDX Financial Health

Explore our TMDX Stock insights

Receive our TMDX Daily Alerts

TMDX Stock IQ

TMDX Street Consensus

TMDX Risk Level

Technical Price Levels

Discover TMDX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of TMDX. We're here to help you make informed investment decisions today.

Receive our TMDX Daily Alerts

TMDX Runner Alarm